Home » Topics » Amgen

Moyers guest: Lobbyist concerns more important to Congress than ‘concerns of middle America’

U.S. Rep. Peter Welch (D-VA) was on Moyers and Company on Friday to discuss a loophole written into the fiscal cliff deal that allows a major biotechnology company to avoid cost controls on certain Medicare drugs — which amounts to a half a billion dollar tax break. The New York…

Senators’ secret plan to give Amgen half a billion in fiscal cliff deal reveals Capitol Hill’s ‘sordid swamp’

The inauguration of a president is one of those spectacles of democracy that can make us remember we’re part of something big and enduring. So for a few hours this past Monday the pomp and circumstance inspired us to think that government of, by, and for the people really is…